Auvelity in Alzheimer’s Agitation:
A Translational Signal from Marble Burying


Newsletter # 133



Animal models


Agitation in Alzheimer’s disease (AD) is clinically characterized by repetitive, distress-driven behaviors such as pacing, vocalizations, and restlessness, reflecting an impaired ability to process environmental stimuli and regulate responses. These symptoms are closely linked to dysregulated glutamatergic signaling, which increases neural “noise” and drives maladaptive behavioral outputs. Importantly, this mechanism now has clear clinical validation: in April 2026, the FDA approved the dextromethorphan/bupropion combination (Auvelity, DM/BUP) for the treatment of agitation associated with Alzheimer’s disease, demonstrating reduced agitation severity and delayed relapse in randomized trials 1.

The mouse marble burying paradigm captures this same core phenomenon of repetitive, stress-induced behavior. When exposed to a novel environment, mice engage in compulsive burying actions that reflect unresolved distress rather than exploration. Neurofit’s data show that DM/BUP combination significantly reduces this marble burying behavior, indicating a selective inhibition of repetitive, stress-driven responses without nonspecific sedation. Mechanistically, this aligns with its NMDA receptor antagonism and stabilization of glutamatergic signaling.


Taken together, the convergence of preclinical and clinical evidence suggests that marble burying is not merely descriptive but predictive: the ability of Auvelity to reduce repetitive distress-driven behavior in mice translates into clinically meaningful reductions in agitation in AD patients.

Marble Burying as a Measure of Repetitive, Distress-Driven Behavior
Open Field Test (Assessment of Locomotor Activity / Sedation)

NEUROFIT offers a range of validated in vitro and in vivo screening tests for psychiatry and neurology.

If you need further information, please do not hesitate to contact us, we will reply within few days. Custom protocol

On a regular basis we distribute newsletters with scientific information on our research services. If you wish to receive these, please :